Home
>
National Drug Code (NDC)
>
Cisplatin
Cisplatin - 63323-103-65 - (CISPLATIN)
Drug Information of Cisplatin
| Product NDC: | 63323-103 |
| Proprietary Name: | Cisplatin |
| Non Proprietary Name: | CISPLATIN |
| Active Ingredient(s): | 1 mg/mL & nbsp; CISPLATIN |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cisplatin
| Product NDC: | 63323-103 |
| Labeler Name: | Fresenius Kabi USA, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074735 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000905 |
Package Information of Cisplatin
| Package NDC: | 63323-103-65 |
| Package Description: | 1 VIAL in 1 CARTON (63323-103-65) > 100 mL in 1 VIAL |
NDC Information of Cisplatin
| NDC Code | 63323-103-65 |
| Proprietary Name | Cisplatin |
| Package Description | 1 VIAL in 1 CARTON (63323-103-65) > 100 mL in 1 VIAL |
| Product NDC | 63323-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CISPLATIN |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20000905 |
| Marketing Category Name | ANDA |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | CISPLATIN |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
